The Efficacy of Ramucirumab in the Treatment of Gastric or Gastroesophageal Junction Cancer: A Meta-Analysis of RCTs

<div>(a) Pooled analysis of overall survival (OS) comparing the application of ramucirumab (RAM) alone or plus chemotherapy with the control (placebo or chemotherapy). (b) Pooled analysis of OS comparing the application of RAM alone or plus chemotherapy with chemotherapy alone.</div>

Gastroenterology Research and Practice

fig2

Figure 2

Figure 2: The Efficacy of Ramucirumab in the Treatment of Gastric or Gastroesophageal Junction Cancer: A Meta-Analysis of RCTs 